Discontinued — last reported Q1 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from BioSig Technologies, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s EBIT?
- BioSig Technologies, Inc. (STEX) reported EBIT of -$35.75M in Q1 2026.
- How has BioSig Technologies, Inc.'s EBIT changed year-over-year?
- BioSig Technologies, Inc.'s EBIT decreased by 1097.9% year-over-year, from -$2.98M to -$35.75M.
- What is the long-term trend for BioSig Technologies, Inc.'s EBIT?
- Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s EBIT has grown at a 20.8% compound annual growth rate (CAGR), from -$33.41M to -$71.1M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.